| Primary information |
|---|
| ID | 16281 |
| Uniprot ID | B6DT16 |
| Description | FMRFamide-like neuropeptides 13 [Cleaved into- SDRPTRAMDSPLIRF-amide; AMDSPLIRF-amide; AADGAPLIRF-amide 1; APEASPFIRF-amide 1; AADGAPLIRF-amide 2; APEASPFIRF-amide 2; ASPSAPLIRF-amide; SPSAVPLIRF-amide; SAAAPLIRF-amide; ASSAPLIRF-amide] |
| Organism | Rhodnius prolixus |
| Txonomy | Caenorhabditis ; Peloderinae ; Rhabditidae ; Rhabditoidea ; Rhabditomorpha ; Rhabditina ; Rhabditida ; Chromadorea ; Nematoda ; Ecdysozoa ; Protostomia ; Bilateria ; Eumetazoa ; Metazoa ; Opisthokonta ; Eukaryota ; cellular organisms |
| Subcellular Location | secreted |
| Developmental Stage | Expressed from the comma stage of embryogenesis; during all larval stages; and in low levels in adults (PubMed-9685599; PubMed-15236235). Expressed in the ALA neuron in L4 stage larvae (PubMed-2754657 |
| Similarity | Orcokinin family |
| Tissue Specificity | Expressed in the ASE sensory neurons; the DD motor neurons; the 15; M3 and M5 cholinergic pharyngeal motoneurons; and the ASG; ASK and BAG neurons. |
| Post Translational Modification | NA |
| Function | Myotropic |
| Length | 160 |
| Molecular Weight | 17 |
| Name | Orcokinin-3(1-11) |
| Sequence | NFDEIDRSGFN |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|